Get the app!
Back to Trades
Grant4

Mallinckrodt plc

NONE

Total Value
$0

Company Information

Company Name
Mallinckrodt plc
Ticker Symbol
NONE
CIK
0001567892

Insider Information

Role
EVP & CHRO
Officer
Location
HAZELWOOD, MO

Filing Details

Filing Date
Aug 4, 2025
Transaction Date
Jul 31, 2025
Accession Number
0001104659-25-073782
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Jul 31, 2025Ordinary Shares782Grant/Award

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Jul 31, 2025Derivative11,409Grant/Award

Footnotes

  1. (F1)On July 31, 2025, pursuant to the Transaction Agreement, dated as of March 13, 2025 (as amended, the "Transaction Agreement"), by and among Mallinckrodt plc (the "Issuer"), Endo, Inc. ("Endo") and Salvare Merger Sub LLC, the Issuer's wholly owned subsidiary ("Merger Sub"), the Merger Sub merged with and into Endo (the "Business Combination"), with Endo surviving the Business Combination as a wholly owned subsidiary of the Issuer. At the Merger Effective Time (as defined in the Transaction Agreement), each share of Endo common stock held by the reporting person immediately prior to the Merger Effective Time automatically converted into the right to receive approximately $1.31 in cash and 0.2575 ordinary shares of the Issuer without interest and subject to applicable withholding.
  2. (F2)Effective at the Merger Effective Time, (i) each restricted stock unit in respect of Endo common stock ("Endo RSU") held by the reporting person immediately prior to the Merger Effective Time automatically converted into a restricted unit in respect of a number of ordinary shares of the Issuer ("Issuer RSU") determined in accordance with the formula set forth in the Transaction Agreement and (ii) each performance-based restricted stock unit in respect of Endo common stock ("Endo PSU") held by the reporting person immediately prior to the Merger Effective Time automatically converted into an Issuer RSU in respect of the number of ordinary shares of the Issuer determined in accordance with the formula set forth in the Transaction Agreement assuming the performance goals were achieved based on target performance.
  3. (F3)The Issuer RSUs will vest ratably on April 23, 2026 and April 23, 2027. Upon vesting, each Issuer RSU will be settled in ordinary shares of the Issuer at one share per Issuer RSU.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.